Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SNY
SNY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SNY News
Sanofi Appoints New Head of R&D Amid Dividend Stock Recognition
2d ago
Yahoo Finance
Snowflake's Strong Growth Outpaces Market Trends
4d ago
NASDAQ.COM
FDA to Announce Multiple Therapy Decisions in July
Jul 01 2026
NASDAQ.COM
Investment Opportunities in Low-Priced High-Yield Stocks
Jun 30 2026
Fool
Analysis of Investment Opportunities in High-Yield Stocks
Jun 30 2026
NASDAQ.COM
Sanofi's Nexviazyme Phase 3 Trial Achieves Key Milestones
Jun 30 2026
NASDAQ.COM
Nexviazyme Achieves Success in Pompe Disease Phase 3 Trial
Jun 30 2026
seekingalpha
EU Opens Antitrust Investigation into Sanofi's Vaccine Campaign
Jun 26 2026
seekingalpha
Sanofi's Cenrifki Approved by EU for SPMS Treatment
Jun 23 2026
NASDAQ.COM
Sanofi's Wayrilz Receives Approval in Japan for ITP Treatment
Jun 23 2026
NASDAQ.COM
Sanofi Signs Memorandum with Abu Dhabi Health Department
Jun 23 2026
Yahoo Finance
Sanofi's Cenrifki Approved in EU for SPMS Treatment
Jun 23 2026
Yahoo Finance
AbbVie Acquires Apogee Therapeutics for $10.9 Billion
Jun 22 2026
Yahoo Finance
Quantum BioPharma Advances MS Drug into Phase 2 Trials
Jun 22 2026
Globenewswire
Quantum BioPharma Advances New MS Drug Candidate Lucid-MS
Jun 22 2026
Newsfilter
Japan Approves Sarclisa Subcutaneous Injection
Jun 22 2026
NASDAQ.COM
Show More News
